Alkaline Phosphatase Isoenzymes (Sendout)

Alkaline Phosphatase: Colorimetric

Alkaline Phosphatase Isoenzymes: Electrophoresis

Interpretation:

Total Alkaline Phosphatase:

Alkaline phosphatase (ALP) elevations tend to be more marked (more than 3-fold) in extrahepatic biliary obstructions (eg, by stone or cancer of the head of the pancreas) than in intrahepatic obstructions: the more complete the obstruction, the greater the elevation. With obstruction, serum ALP activities may reach 10 to 12 times the upper limit of normal, returning to normal upon surgical removal of the obstruction. The ALP response to cholestatic liver disease is similar to the response of gamma-glutamyltransferase (GGT) but more blunted. If both GGT and ALP are elevated, a liver source of the ALP is likely.

Among bone diseases, the highest level of ALP activity is encountered in Paget disease, because of the action of the osteoblastic cells as they try to rebuild bone that is being resorbed by the uncontrolled activity of osteoclasts. Values from 10 to 25 times the upper limit of normal are not unusual. Only moderate rises are observed in osteomalacia, while levels are generally normal in osteoporosis. In rickets, levels 2 to 4 times normal may be observed. Primary and secondary hyperparathyroidism are associated with slight to moderate elevations of ALP; the existence and degree of elevation reflects the presence and extent of skeletal involvement. Very high enzyme levels are present in patients with osteogenic bone cancer. A considerable rise in ALP is seen in children following accelerated bone growth.

ALP increases of 2 to 3 times normal may be observed in women in the third trimester of pregnancy, although the reference interval is very wide, and levels may not exceed the upper limit of normal in some cases. In pregnancy, the additional enzyme is of placental origin.

ALP Isoenzymes:

Liver ALP isoenzyme is associated with biliary epithelium and is elevated in cholestatic processes. Various liver diseases (primary or secondary cancer, biliary obstruction) increase the liver isoenzyme.

Liver 1 is increased in some nonmalignant diseases (such as cholestasis, cirrhosis, viral hepatitis, and in various biliary and hepatic pathologies). It is also increased in malignancies with hepatic metastasis, in cancer of the lungs and digestive tract, and in lymphoma.

An increase of liver 2 may occur in cholestasis and biliary diseases (eg, cirrhosis, viral hepatitis) and in malignancies (eg, breast, liver, lung, prostate, digestive tract) with liver metastasis.

Osteoblastic bone tumors and hyperactivity of osteoblasts involved in bone remodeling (eg, Paget disease) increase the bone isoenzyme. Paget disease leads to a striking, solitary elevation of bone ALP.

The intestinal isoenzyme may be increased in patients with cirrhosis and in individuals who are blood group O or B secretors.

The placental (carcino-placental antigen) and Regan isoenzyme can be elevated in cancer patients.

Outside Laboratories: Centrifuge sample. Aliquot an equal amount of serum into two separate plastic vials. Freeze aliquots at -20°C.

Stability: Frozen (Preferred): 14 days; Refrigerated: 7 days; Ambient: 7 days.

Reject Due To: Gross hemolysis. Gross lipemia, gross icterus are acceptable.

Centrifuge sample. Aliquot an equal amount of serum into two separate plastic vials. Freeze aliquots at -20°C.

Sendouts:

• Order Mayo Test: ALKI.
• Interfaced: Yes.
• If only one frozen serum aliquot is received, do not thaw/split. Okay to send a single aliquot to Mayo as long as there is sufficient volume.

Stability: Frozen (Preferred): 14 days; Refrigerated: 7 days; Ambient: 7 days.

Reject Due To: Gross hemolysis. Gross lipemia, gross icterus are acceptable.